Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Plaque Psoriasis”

523 trials

Showing 20 of 523 results

Early research (Phase 1)UnknownNCT05258331
What this trial is testing

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
GC Cell Corporation 24
Testing effectiveness (Phase 2)Study completedNCT00428974
What this trial is testing

Safety and Efficacy Study of CF101 to Treat Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 76
Large-scale testing (Phase 3)WithdrawnNCT01900782
What this trial is testing

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01622348
What this trial is testing

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Actively Extending Plaque PsoriasisModerate to Severe Plaque Psoriasis
Idera Pharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT06176768
What this trial is testing

LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 33
Large-scale testing (Phase 3)Study completedNCT03518047
What this trial is testing

Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation

Who this might be right for
Psoriasis
AbbVie 50
Large-scale testing (Phase 3)WithdrawnNCT02795416
What this trial is testing

Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Post-approval studies (Phase 4)Study completedNCT03718299
What this trial is testing

A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries Limited 55
Large-scale testing (Phase 3)Study completedNCT01646177
What this trial is testing

A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,346
Large-scale testing (Phase 3)Study completedNCT05637515
What this trial is testing

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque Psoriasis
Biocon Biologics Inc. 374
Large-scale testing (Phase 3)Study completedNCT03123471
What this trial is testing

The Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

Who this might be right for
Psoriasis
Amgen 303
Large-scale testing (Phase 3)Study completedNCT00710580
What this trial is testing

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 350
Testing effectiveness (Phase 2)Study completedNCT01132612
What this trial is testing

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 275
Testing effectiveness (Phase 2)Study completedNCT02129777
What this trial is testing

Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 122
Testing effectiveness (Phase 2)Study completedNCT03463187
What this trial is testing

Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 211
Post-approval studies (Phase 4)WithdrawnNCT04614298
What this trial is testing

Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Kyowa Kirin Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT01690299
What this trial is testing

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Who this might be right for
PsoriasisPsoriatic Arthritis
Amgen 250
Testing effectiveness (Phase 2)Study completedNCT00645814
What this trial is testing

Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 148
Large-scale testing (Phase 3)Study completedNCT02634801
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 162
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation